市場調查報告書
商品編碼
1497617
心血管導管市場:按導管、按應用、按最終用戶分類 - 2024-2030 年全球預測Cardiovascular Catheters Market by Catheters (Electrophysiology Catheters, Guide Extension Catheter, Intravascular Ultrasound Catheters), Usability (Disposable, Reusable), End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年心血管導管市場規模為127.9億美元,預計2024年將達137.1億美元,2030年將達211億美元,複合年成長率為7.41%。
心血管導管是一種專門的醫療設備,設計用於在血管內導航以執行涉及心臟和心血管系統其他部分的治療和診斷程序。它是一種長而細的管狀裝置,在影像引導下透過循環系統引導指定。隨著世界各地受心血管疾病影響的人數不斷增加,對心血管導管等有效診斷和治療解決方案的需求日益成長。政府努力提高人們對心臟健康和心臟病的認知,再加上診所、醫院、外科和診斷中心的擴張,正在加速心血管導管等關鍵醫療設備的採用。然而,導管插入術技術複雜,需要高技能的專業人員,這可能會限制在缺乏專業醫療人員的地區進行此類手術。性能和安全性問題,例如感染和污染的風險以及設備故障,可能會引起人們對心血管導管可靠性的擔憂。導管技術的創新,例如開發更靈活和耐用的材料以及提高基於導管的干涉措施的精度,可以擴大心臟病治療的範圍和有效性。
主要市場統計 | |
---|---|
基準年[2023] | 127.9億美元 |
預測年份 [2024] | 137.1億美元 |
預測年份 [2030] | 211億美元 |
複合年成長率(%) | 7.41% |
區域洞察
由於飲食和生活方式的變化以及人口老化,美洲地區心血管疾病的盛行率很高,特別是在美國和加拿大。美洲的醫療保健提供者擴大採用先進技術來管理心血管疾病,增加了對先進心血管導管進行診斷和治療的需求。研究和開發投資得到私人和公共資金的支持。該地區最近的專利主要集中在導管耐用性和診斷準確性方面的創新。歐盟國家受益於完善的醫療保健系統和統一的監管標準,這有助於獲得和實施包括心血管導管在內的新醫療技術。重點在於提高心血管導管的親和性,研發工作正在積極進行。在亞太地區,由於人口老化的增加和文明病的蔓延,中國和日本對心血管導管的需求不斷增加。在政府旨在整合更先進醫療技術的措施的支持下,亞太地區國家正在迅速擴大其醫療保健基礎設施。農村和偏遠地區醫療保健設施的擴張以及醫療設備本地製造的促進將促進亞太地區心血管導管的成長。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在心血管導管市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對心血管導管市場供應商的現況進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭力的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在心血管導管市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[198 Pages Report] The Cardiovascular Catheters Market size was estimated at USD 12.79 billion in 2023 and expected to reach USD 13.71 billion in 2024, at a CAGR 7.41% to reach USD 21.10 billion by 2030.
Cardiovascular catheters are specialized medical devices designed for navigating through blood vessels to deliver therapies or perform diagnostic procedures relating to the heart and other parts of the cardiovascular system. They are slender, tube-like instruments that are guided into place through the circulatory system under imaging guidance. With increasing numbers of individuals affected by cardiovascular conditions worldwide, there is a growing need for effective diagnostic and therapeutic solutions such as cardiovascular catheters. Government initiatives to raise awareness for heart health and heart conditions, coupled with the expansion of clinics, hospitals, and surgical and diagnostics centers, have accentuated the adoption of critical medical devices such as cardiovascular catheters. However, the technical complexity of catheterization requires highly skilled professionals, which can restrict the availability of these procedures in regions with shortages of specialized healthcare providers. Performance and safety issues such as risks of infection and contamination and malfunctioning of the device can raise concerns about the reliability of cardiovascular catheters. Innovations in catheter technology, including the development of more flexible and durable materials, as well as enhancements in the precision of catheter-based interventions, can expand the scope and effectiveness of treatments available for heart diseases.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 12.79 billion |
Estimated Year [2024] | USD 13.71 billion |
Forecast Year [2030] | USD 21.10 billion |
CAGR (%) | 7.41% |
Regional Insights
In the Americas, particularly the United States and Canada, there is a high prevalence of cardiovascular diseases owing to dietary and lifestyle changes and an aging population. Healthcare providers in the Americas region are increasingly adopting advanced technologies for managing cardiovascular conditions, driving the need for sophisticated cardiovascular catheters for diagnosis and treatment. Investment in research and development is robust, supported by both private and public funding. Recent patents in the region have focused on innovations in catheter durability and the precision of diagnostic features. EU countries benefit from well-established healthcare systems and uniform regulatory standards, which enhance the accessibility and adoption of new medical technologies, including cardiovascular catheters. There is a heightened focus on improving the biocompatibility of cardiovascular catheters, giving rise to robust R&D initiatives. In the APAC region, China and Japan present a need for cardiovascular catheters due to large aging populations and the increasing prevalence of lifestyle diseases. APAC nations are rapidly expanding their healthcare infrastructure, supported by governmental initiatives aimed at incorporating more advanced medical technologies. The expansion of healthcare facilities in rural and remote locations and a heightened emphasis on advancing local manufacturing of medical devices provide a conducive framework for the growth of cardiovascular catheters in the APAC region.
Market Insights
The market dynamics represent an ever-changing landscape of the Cardiovascular Catheters Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cardiovascular Catheters Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cardiovascular Catheters Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Cook Medical Partners with Bentley to Distribute BeBack Crossing Catheter in the USA
Cook Medical has entered into a distribution agreement with Bentley to market the BeBack crossing catheter in the United States, enhancing Cook's peripheral intervention portfolio. This collaboration enables greater access to the BeBack device, which is essential for navigating chronic total occlusions (CTO) and facilitating precise re-entry, particularly in heavily calcified lesions. [Published On: 2024-03-21]
Introduction of the Micro Rx Microcatheter by Biotronik, Enhancing Guidewire Support in Percutaneous Coronary Interventions
Biotronik has introduced the Micro Rx microcatheter in the USA, a cutting-edge device designed to improve guidewire support during percutaneous coronary interventions (PCI). This rapid exchange microcatheter, the fourth product from Interventional Medical Device Solutions (IMDS) distributed by Biotronik in the U.S. market, features a robust design with a reinforced distal shaft and a core wire sandwiched between two braiding layers to ensure efficient push transfer. I [Published On: 2024-02-08]
Introduction of Enhanced Shockwave C2+ Catheter Promises Improved Cardiovascular Treatment
Shockwave Medical is set to introduce its advanced Shockwave C2+ coronary intravascular lithotripsy (IVL) catheter at the Transcatheter Cardiovascular Therapeutics (TCT) symposium. The C2+ catheter aims to improve procedural efficiency and is already marketed for treating de novo coronary artery disease in the U.S., Europe, and other regions. The company highlighted the device's enhanced capacity to treat complex calcium cases in cardiovascular procedures including diffuse disease and eccentric calcifications. [Published On: 2023-10-20]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cardiovascular Catheters Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Cardiovascular Catheters Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics Inc., Asahi Intecc Co., Ltd., B. Braun SE, Becton, Dickinson and Company, Boston Scientific Corp., Cardinal Health, Coloplast Corp., Cook Group Incorporated, Cordis Corporation, Edwards Lifesciences, Getinge AB, Infraredx by Nipro Corp., Integer Holdings Corp., Johnson & Johnson Services, Inc., McKesson Medical-Surgical Inc., Medtronic PLC, Merit Medical Systems, Microport Scientific Corp., Penumbra, Inc., Smith+Nephew PLC, Stryker Corporation, Teleflex Inc., and Terumo Corporation.
Market Segmentation & Coverage